To increase the efficiency and effectiveness of clinical research studies, cerebral palsy (CP) specific Common Data Elements (CDEs) were developed through a partnership between the National Institute of Neurological Disorders and Stroke (NINDS) and the American Academy of Cerebral Palsy and Developmental Medicine (AACPDM). International experts reviewed existing NINDS CDEs and tools used in studies of children and young people with CP. CDEs were compiled, subjected to internal review, and posted online for external public comment in September 2016. Guided by the International Classification of Functioning, Disability and Health framework, CDEs were categorized into six domains: (1) participant characteristics; (2) health, growth, and genetics; (3) neuroimaging; (4) neuromotor skills and functional assessments; (5) neurocognitive, social, and emotional assessments; and (6) engagement and quality of life. Version 1.0 of the NINDS/AACPDM CDEs for CP is publicly available on the NINDS CDE and AACPDM websites. Global use of CDEs for CP will standardize data collection, improve data quality, and facilitate comparisons across studies. Ongoing collaboration with international colleagues, industry, and people with CP and their families will provide meaningful feedback and updates as additional evidence is obtained. These CDEs are recommended for NINDS-funded research for CP.
neurological diseases for adult and paediatric populations for NINDS-funded clinical studies. However, NINDS CDEs were not available for children and young people with cerebral palsy (CP). Moreover, the need to develop a common data set of meaningful measurements for CP was identified as a priority area of the 2013-2017 strategic plan developed by the American Academy of Cerebral Palsy and Developmental Medicine (AACPDM).
CP describes a group of disorders that affect the development of movement and posture, causing activity limitations, which are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. 3 The motor disorders of CP are often accompanied by disturbances of sensation, cognition, communication, perception, and/or behaviour and/or by a seizure disorder. 3 Since the 2001 publication of the International Classification of Functioning, Disability and Health (ICF) 4 there has been increased interest in not only standardizing data collection, but also in understanding the functional abilities of individuals living with CP and the challenges they face in performing everyday activities. After the publication of the ICF for children and young people in 2007, 5 ICFbased tools -entitled ICF Core Sets 6 -were developed for children and young people with CP worldwide. The ICF Core Sets serve as useful tools to standardize the description of the functional abilities and challenges children and young people with CP have in performing everyday activities, and the contextual factors that facilitate or hinder functioning. Subsequently, an ICF-based toolbox of multiple-item measures (e.g. questionnaires, standardized tests) was proposed. 7 This newly developed toolbox guides how to measure the relevant areas of functioning, disability, and health included in the ICF Core Sets for CP. Hence, international initiatives -such as the CDEs and ICF-based tools -have recognized the importance of universal, standardized, and comprehensive data collection. Despite differences in methodological approaches, the CDEs and ICF-based tools put special emphasis on measures for CP. 6, 7 Previous reviews have compared measures used in CP, providing valuable information on measurement characteristics and theoretical backgrounds of a range of measures. [8] [9] [10] [11] [12] [13] [14] A recent systematic review of outcome measures used in studies with children and young people with CP showed that clinicians and researchers used different measures to assess the same concept/construct. 15 This finding demonstrates the variability in practice and lack of consensus on data collection, challenging the interpretation of results. To address this issue, the AACPDM partnered with the NINDS CDE team to create the paediatric CDEs for CP. This paper reviews the process by which experts gathered in working groups and developed the first version of CDEs for children and young people with CP.
The goals of the NINDS CDE project are to: (1) disseminate standards for data collected from participants enrolled in studies of neurological diseases; (2) create easily accessible tools for clinical study data collection -these tools should be especially helpful to new investigators and others working with limited budgets; (3) encourage focused and simplified data collection to reduce burden on investigators and practice-based clinicians to facilitate their participation in clinical research; (4) improve data quality while controlling cost by providing uniform data descriptions and tools across NINDS-funded clinical studies. 1 The overall aim of this NINDS/AACPDM CDE project was to standardize data collection and assessment in studies of children and young people with CP by: (1) recommending a set of CDEs and tools that comprehensively represent functional profiles; (2) identifying valid and reliable measures to be recommended for routine use across NINDS-funded clinical studies and clinical practice; (3) identifying CDEs/measurement gaps that could be addressed in future research initiatives.
METHOD Development of NINDS/AACPDM CDEs for children and young people with CP
The CDE project for CP began in 2015. An organizing committee with representatives from AACPDM and the NINDS was convened at an international meeting. AACPDM leadership created a Steering Committee and worked with the AACPDM Research Committee to invite experts in CP into working groups, each of which was composed of five to seven members with knowledge and experience relevant to CP-related health domains. These experts included epidemiologists, clinicians, clinical researchers, educators, and clinical trial experts. The working groups were organized into the following domains: (1) participant characteristics; (2) health, growth, genetics, comorbidities, and labs; (3) neuroimaging diagnostics; (4) neuromotor skill and functional assessments; (5) neurocognitive, social, and emotional assessments; (6) engagement and quality of life assessments. Moreover, the integrated across working group was created to oversee the data. Composition of each working group is provided in Appendix S1, online supporting information.
The Chair of each working group, together with their Steering Committee liaison, constituted an advisory team that communicated throughout the development phase to coordinate goals and identify shared solutions. Each working group was tasked with identifying existing CDEs and/ or tools in the assigned domain and providing recommendations for their use in clinical studies with children and young people with CP. The working groups developed CRFs by selecting the most relevant items from existing NINDS CDEs and tools for other diagnoses, or identified
What this paper adds
• This is the first comprehensive Common Data Elements (CDEs) for children and young people with CP for clinical research.
• The CDEs for children and young people with CP include common definitions, the standardization of case report forms, and measures.
• The CDE guides the standardization for data collection and outcome evaluation in all types of studies with children and young people with CP.
• The CDE ultimately improves data quality and data sharing.
Reviewand recommended the use of copyrighted tools for CP. When necessary, they developed new CDEs and recommendations de novo. Brief details of how this was accomplished in individual working groups are described later. Assessment measures and/or outcome measures were selected based on the reliability and validity of the tool in children and young people with CP. Tools could be a single question (single-item measure), a questionnaire (multiple-item measure), a score obtained through physical examination, a laboratory measurement, or a score obtained through observation of an image.
Terminology of NINDS CDEs
Consistent with guidance across the NINDS CDE project, the working groups were charged with classifying each recommended CDE and tools as 'Core', 'SupplementalHighly Recommended', 'Supplemental', or 'Exploratory' (Table I) .
Conceptual framework
Managing the depth and breadth of data related to CP required an organizational framework to help visualize the essential data categories. Given the multidimensional impact of having CP on developmental trajectories of children and young people and their families, [16] [17] [18] [19] [20] it was essential to use a comprehensive framework such as the ICF. 4 Hence, NINDS domains were populated with the most appropriate CDEs and measures incorporating the ICF components (Fig. 1) .
CDE revision process and selection criteria
Individual working groups met via teleconference monthly for 6 to 9 months. As a starting point, all working groups reviewed the existing list of CDEs and tools previously defined from other diagnostic groups, including Friedrich's ataxia, stroke, epilepsy, Duchenne muscular dystrophy/Becker muscular dystrophy, spinal muscular atrophy, and traumatic brain injury, in the NINDS CDE project.
The following selection criteria were applied by all working groups: (1) applicable to children and young people aged 0 to 18 years; (2) represents relevant areas of study in CP; and (3) has documented validity and reliability. Each of the working groups proceeded with slightly different approaches that were largely dependent on the status of existing data standards and elements (see 'Individual methods of each of the working groups'). CDEs and tools had to meet all selection criteria to be included in the final set for CP.
After compiling the CDEs and definition tables, recommendations, and CRFs from each of the working groups representing the six CDE domains, the draft documents were sent to the integrated across working group to look for gaps, overlaps, and to make recommendations for the inclusion of CDEs and tools. Descriptive analysis was conducted to remove duplications and identify distribution of CDEs by level of recommendation. Subsequently, all the measures recommended as 'Supplemental -Highly Recommended' were mapped into the ICF components and chapters. Revised documents were then disseminated for internal review by the full panel of working group experts, the Steering Committee, and the NINDS CDE project team (June 2016). The draft CDEs for CP were posted on the NINDS CDE website for public review from September 2016 to October 2016. The final version, Version 1.0 NINDS CDEs for CP, was posted on the NINDS CDE website on December 15th, 2016 after the incorporation of comments received from the public review (Fig. 1) .
Individual methods of each of the working groups Participant characteristics
This working group conducted a review of common data variables collected by CP registers from around the world, 21 most notably demographic and disease classification data elements, to ensure that the CDEs for this initiative were inclusive. All CDEs and tools selected were reviewed and discussed by the members of the working groups to determine the classification (core or supplement) based on the NINDS classification criteria.
Health, growth, genetics, comorbidities, and labs
Each working group member independently reviewed 500 already established CDEs to determine if it applied to CP and to the health, growth, genetics, comorbidities, or labs topic areas. Each element was reviewed by two working group members; in the case of disagreement, the element was discussed by the working group and a resolution was reached. Working group members independently drafted modifications to existing CRFs for other diseases, or created new CRFs if needed, and the draft was discussed by the group during a teleconference to create updated versions of each CRF.
Engagement and quality of life assessments/data
The working group developed a list of measures for review by surveying systematic reviews and reviewing the literature on engagement and quality of life tools used with children with CP. The list of tools was distributed among the working group members for review and additional measures were added based on clinical expertise. A literature review was performed for each measure by a member of the working group using the NINDS/AACPDMdefined selection criteria. Preference was given to validated measures that were developed for children with CP. Using the tabulated information, all measures were reviewed and discussed to determine the appropriate classification based on the NINDS classification criteria.
Neuroimaging diagnostics
The working group searched for existing tools that were developed for documenting or interpreting neuroimaging findings in children with CP and infants and children at risk of developing CP. While there were no commonly accepted tools/tools for neuroimaging in CP, several neuroimaging assessment tools were identified and included. Published reports of abnormal brain magnetic resonance imaging (MRI) findings in children with CP were reviewed.
This working group focused on developing CDEs and a CRF to document the characteristics and findings obtained using conventional clinical MRI of the brain. The working group decided to defer the development of CDEs or CRFs for diffusion tensor imaging, although diffusion tensor imaging is a promising neuroimaging tool for studying brain microstructure in children with CP. The working group did not specifically address use of ultrasound, computed tomography, or functional MRI.
Neuromotor skills and functional assessments
The Chair of the working group reviewed CDEs and tools related to physical and neurologic examination, neuromotor skills, physical function assessments, rehabilitation therapies, and adaptive equipment that were included for other disease groups. The entire working group reviewed these CDEs and tools, and narrowed this list to include those that were applicable to CP. Working group members were then assigned to CDE areas that matched their areas of expertise and each member performed an electronic search for systematic and narrative reviews to identify tools that Reviewwere deemed most reliable and psychometrically sound. Tools were selected that were psychometrically sound, commonly used in CP research for children aged 0 to 18 years, filled gaps in outcome measures/functional assessments, or were promising. Many CDEs that were already in use for other disease groups were modified to fit the accepted nomenclature for CP as determined through a review of literature. When the working groups could not identify a CDE that captured the important information, a new CDE was created. When questions arose, consensus was reached through discussion. A particularly critical focus for this working group was to identify and collate occupational therapy, physical therapy, and speech and language pathology CDEs and tools. Specifically, occupational therapy, physical therapy, and speech and language pathology CDEs were selected based on gaps and needs in rehabilitation research (the need to determine the association between frequency, intensity, timing, and type of rehabilitation intervention and outcomes), published literature, and clinical expertise. The CDEs and created CRFs were based on three key articles, [22] [23] [24] reviewed by three or more therapists in each discipline, and modified to reflect CP practice.
Neurocognitive, social, and emotional assessments
This working group reviewed CDEs from other paediatric diagnoses, including spinal cord injury -paediatrics, mitochondrial disease -paediatrics, Duchenne muscular dystrophy/Becker muscular dystrophy, epilepsy (diagnosis by age included), and traumatic brain injury -including early childhood. Like CP, these diagnoses are predominately motor diseases often with some communicative and cognitive impairment. The working group finalized specific domains considered to be of central importance for CP. Outcome measures for the domains: language -speech, expressive, and receptive; cognitive and neurocognitive executive function; intelligence and general cognition; executive function and attention; adaptive behaviour; developmental milestones for the infant/toddler age range; social-emotional development; and behavioural problems were considered for inclusion/exclusion. In discussions, this working group strongly advocated that clinical and longitudinal studies of individuals with CP be considered, which included several assessments that capture important aspects of cognitive and social-emotional development.
RESULTS
The complete list of CDEs and tools and recommendation for their use can be found on the NINDS CDEs (https:// www.commondataelements.ninds.nih.gov/#page=Default) and AACPDM (http://www.aacpdm.org/) websites. Overall, few CDEs were classified as 'Core' and 'Supplemental -Highly Recommended'. None of the measures was classified as 'Core'. A summary of CDEs classified as 'Core and Supplemental -Highly Recommended' is available in Appendix S2, online supporting information. A brief description of the working group findings is provided in the following subsections.
Participant characteristics
The few CDEs classified as 'Core' included date of birth, country of birth, country of residence, and sex. Only four tools were specific to individuals with CP. CDEs classified as 'Supplemental -Highly Recommended' were maternal date of birth, level of education attained, health insurance, postneonatal onset (exact cause), gestational age, birthweight, multiple birth, predominant, and secondary motor type. Many CDEs identified by this working group were classified as 'Supplemental'.
Health, growth, genetics, comorbidities, and labs
The 'Supplemental' elements proposed are expected to be used depending on the focus of a given clinical trial. Efforts were made to give general and supporting additional levels of detail that may be appropriate for a given study. Checklists and tables were used for the history forms to facilitate efficient data collection. There are a few 'Supplemental -Highly Recommended' variables that should be prioritized if collecting data related to those constructs. In the review of existing CDEs, many relevant CDEs were identified but were validated in diseases other than CP; therefore, these were classified as 'Exploratory'.
Engagement and quality of life assessments
No tools reviewed by the group were classified as 'Core'. Only three quality of life measures were classified as 'Supplemental -Highly Recommended (Disease Specific)'. The remaining quality of life measures were classified as 'Exploratory' owing to their limited use in children with CP and limited age range. For participation measures, only three measures were classified as 'Supplemental -Highly Recommended' as they have been widely used in the assessment of participation in children with CP and have demonstrated good psychometric properties in individuals with CP. Many of the tools reviewed were not specific for, or differentiated between, types or levels of CP motor impairment.
Neuroimaging and diagnostics
This working group included a comprehensive list of CDEs that would allow for coding and documentation of lesions that would be found in any of the types of CP, i.e. spastic CP (cortical lesions, periventricular white matter injury, and diffuse white matter injury), dyskinetic CP (basal ganglia lesions), ataxic CP (cerebellar lesions), or mixed types. The CRF developed allows for documentation of both acute and chronic changes on a single form. Future efforts should focus on classification of structural MRI findings, interpretation, and prognostication based on those findings.
Neuromotor skills and functional assessments
A total of 92 tools were included (Table II) . No tools were classified as 'Core'. Twelve tools inclusive of ICF domains of body structures and functions and activities and participation were categorized as 'Supplemental -Highly Recommended' (Table III) . Specific tolls included in the 'Supplemental -Highly Recommended' group included Gross Motor Function Classification System -Expanded and Revised, Manual Ability Classification System, Eating and Drinking Ability Classification System, and Communication Function Classification System. Sixty-nine tools were classified as 'Supplemental'. Eleven tools were categorized as 'Exploratory'.
Neurocognitive, social, and emotional assessments
This working group included standardized assessments of neurocognitive and social-emotional development that capture the full developmental potential of children with CP, from the youngest ages through to and including adulthood. The working group identified many standardized tools designed originally for children who are typically developing that are included in studies of children with CP but have not necessarily been subjected to formal psychometric inquiry. Further, tests for younger children have often been used with older children with CP when their developmental stage seems matched to the research question (e.g. children who are age-delayed in language acquisition). In many but not all study samples, the assessors make reasonable accommodations as to how they administer the test or the timing of the items, adjusting to the individual profile of a child with CP. To what extent this alters the reported reliability and validity estimates is seldom known with high levels of confidence.
Integrated across working group
The integrated across working group compiled and reviewed all the tools that the six other working groups recommended (Table II) . As expected, a vast number of measures were identified by the working groups (n=226). Of the initial 226 tools reviewed by the working groups, 122 (54%) were proposed for inclusion in Version 1.0 CP CDEs. Of these, 34 were classified as 'SupplementalHighly Recommended'; 61 as 'Supplemental'; and 31 as 'Exploratory'. Of note, some valuable classification systems specific for CP -Gross Motor Function Classification System, Manual Ability Classification System, and Communication Function Classification System -were included within the list of 'Supplemental -Highly Recommended' tools by different working groups. In addition, 11 CRFs were recommended by the working groups (Table II) . An example of a recommended CRF can be found in Appendix S3, online supporting information. Table III shows the tools recommended as 'Supplemental -Highly Recommended' by the working groups. In addition, tools are organized by NINDS domains, ICF components, and ICF chapters. The tools highly represented the ICF component body functions followed by the component activities and participation; many measures covered areas of neuromusculoskeletal and movementrelated functions, intellectual functions, general tasks and demands, and mobility.
DISCUSSION
The NINDS/AACPDM CDEs for children and young people with CP (Version 1.0) are now available for clinical practice and research. The proposed CDEs for CP are the starting point to achieving standardization and universal data collection across NINDS-funded clinical studies. Benefits of the widespread use of these CDEs include facilitating data sharing across a wide range of study types. Importantly, sharing CDEs and cross-referencing with other international measurement initiatives for CP will enable a common language across the full spectrum of clinical research studies worldwide. While many of the CDEs for CP are used across other domains and diseases, some of the CDEs were created de novo and will require further scrutiny regarding use for CP research. In addition, measures for CP continue to be developed and others improved upon. With the creation of the CDEs for children and young people with CP (Version 1.0), we hope that this will encourage researchers to continue this process along with creating and validating measures to fill gaps in research for children and young people with CP.
Following the CDE recommendations for CP, researchers and clinicians can select the most appropriate set of CDEs to best design and conduct their research or clinical study. Tutorials demonstrating how to access and apply the CDEs are available on the NINDS CDE website. In addition, a demonstration video was created to illustrate how to access, select, and apply the CDEs for CP (https:// www.youtube.com/watch?v=C9CqmFAHtvE).
Challenges creating CDEs for CP
The biggest challenge when creating the CDEs for CP was the heterogeneity of the condition, with regards to both clinical presentation and aetiology.
Health, growth, genetics, comorbidities, and labs
There is no genetic or other test to biologically confirm the diagnosis, and laboratory tests that may be related to comorbidities were thought to be more extensive than reasonable for the first iteration of CDE recommendations. NA, not applicable.
Review

Engagement and quality of life assessments/data
Identifying one engagement or quality of life tool was difficult. Many of the tools reviewed were not specific for children with CP. For individuals with CP who are non-verbal or who have cognitive impairments as a component of their CP, assessment of quality of life is a difficult construct to measure, and validated proxy and self-report options are limited.
Neuroimaging diagnostics
In contrast to CP, CRFs developed for other neurological disorders and populations are more homogeneous and the types of findings are narrower. CP has many aetiologies and there can be a wide range of findings; therefore, it is important that a neuroimaging CRF allows for data collection of any relevant findings. Comprehensive evaluation is important for analysis and meta-analysis in future studies to better understand the neural structure function relations vital to improving function in CP. Also, it is challenging to allow for documentation of both acute findings (recent injury) and chronic findings that would be relevant to development of CP. This working group developed a useful CRF that can be utilized for documenting both acute and chronic findings among the different types of CP.
Neuromotor skills and functional assessments
CP is a heterogeneous disorder in aetiology and phenotype. Therefore, identifying tools that (1) spanned the CP type and functional ability; (2) were psychometrically PEM-CY [64] [65] [66] PedsQL-CP sound; and (3) were specific to individuals with CP was challenging. Furthermore, while therapies are key interventions in CP, there has not been a standardized method for documenting and reporting on therapy interventions. Therefore, this working group created CRFs for therapies (physical, occupational, speech/language) to facilitate systematic reporting on specific therapeutic interventions, duration, and intensity of interventions.
Comparison to other international CP standards CP registers throughout the world were used as a starting point. 21 Where there was full agreement amongst registers, those items were included and measured in the same way. Medical, surgical, and family history forms are consistent with the type of information collected by CP registries around the world.
In terms of CDEs related to neuroimaging, conventional MRI of the brain is the imaging modality of choice for clinical diagnostic evaluation of children with CP and is consistent with the practice parameter 'Diagnostic Assessment of the Child with CP' of the American Academy of Neurology, 70 as well as the practice parameters of other international groups. Moreover, the Surveillance of Cerebral Palsy in Europe group published a classification system for standardizing the abnormal findings of brain MRI in children with CP. 71 Their approach was different from the NINDS CDE project in that they tried to define categories of patterns of involvement for research studies. The NINDS CDE for CP approach was to promote coding and documentation of all abnormal findings in a consistent manner but with less focus on interpretation and categorizing patterns of involvement. The tool developed by Surveillance of Cerebral Palsy in Europe would be useful for research and complementary to the CRF developed for this project, and both could be used together.
The NINDS CDEs for CP are comparable to CDEs for other medical conditions, including Friedrich's ataxia, stroke, epilepsy, Duchenne muscular dystrophy/Becker muscular dystrophy, spinal muscular atrophy, and traumatic brain injury. However, terminology used for these other diagnoses is not consistent with currently accepted terminology based on published consensus statements of experts. 72 For example, while hemiplegia, diplegia, and quadriplegia are frequently used in other disorders, there can be imprecision with this classification in CP. 73 Thus, we sought to also encourage the use of 'unilateral' and 'bilateral' CP, as recommended by expert consensus. 72 Tools were reviewed from systematic and narrative reviews in the CP literature, when those existed. 15, [74] [75] [76] [77] [78] [79] [80] [81] [82] Occupational therapy, physical therapy, and speech and language pathology recommendations are based on published data elements (modified to reflect CP practice) and are aligned with discipline-specific standards of practice and current research. 22, 24, 83 When we compared the what and the how to measure common information proposed by the NINDS/AACPDM CDEs for CP (Version 1.0) to other newly developed international standards, specifically the ICF Core Sets for children and young people with CP, 6 which highlight what areas of functioning, disability, and health should be measured in this population, we found commonalities and differences. The landmark characteristics of CP are captured by both standards, including movement and posture disorders, communication, cognition, and musculoskeletal challenges, among others. However, some relevant areas are under-represented by the current version of the CDEs, for example sensation of pain, sensory functions, sleep functions, support and attitude of peers, role of products and technology -including assistive devices for daily living, education, and recreation. When we compared the how to measure relevant areas in CP -proposed by the NINDS/ AACPDM set of tools -to the recently developed ICFbased toolbox of measures for CP, 7 we found that the NINDS/AACPDM includes a much more comprehensive set of tools, including single-item and multiple-item measures. However, the NINDS/AACPDM recommended tools highly represent the ICF component body functions, whereas the ICF-based toolbox of measures focuses mainly on the ICF component activities and participation.
Considerations for future CDE revisions
There is currently no definitive 'classification of aetiology' of CP owing to the heterogeneous nature of the disorder and because there is very rarely one definitive cause, rather a causal pathway that contains any number of risk factors. If classifications for aetiology are developed, they should be incorporated into the CP CDEs. In addition, further expansion of commonly used laboratory tests should be considered in future revisions.
Coding systems for evaluating different structures in the brain by neuroimaging will gradually become more refined. The various aetiologies of CP will be increasingly correlated with specific neuroimaging findings. This research will need to be incorporated into the CDE framework for neuroimaging in CP. CDEs for newer neuroimaging modalities (e.g. diffusion tensor imaging and functional MRI) relevant to CP will need to be developed.
Owing to the wide spectrum of abilities and limitations of individuals with CP, the development of tools specific to anatomical distribution, unilateral or bilateral, or the functional level of individuals with CP would be beneficial.
While there are well-known tools for spasticity and dystonia assessments in CP, there are as yet no tools to classify hypotonia. Furthermore, tools to assess a child's engagement in therapy and measure the impact that participation has on the outcomes of therapy are needed. Finally, given the breadth of the CDEs and instruments, the working groups did not explore CDEs or tools to assess surgical interventions and surgical outcomes in CP. Creation of an interdisciplinary surgical working group for the next version of the CDEs for CP is recommended.
From an ICF perspective, future revisions should include all relevant areas of functioning, disability, and health highlighted in the ICF Core Sets for children and young people with CP, incorporating measures addressing functional impact of chronic pain and sleep disturbances in day-to-day functioning. Further expansion of self-report measures capturing activities and participation constructs should be considered in future revisions.
Finally, although CP is a life-long disability, many measures for CP are focused on paediatrics. Measures for children and young people with CP have been used to evaluate adults with CP, but the psychometric properties have not been studied. In addition, measures developed for adults with other types of disability may be useful but have not been validated for adults with CP. The development of a working group to examine this need is recommended.
Future directions
Of note, Version 1.0 of NINDS CDEs for CP is the starting point; CDEs are dynamic and will evolve over time. It is expected that future revisions will incorporate the valuable perspective of parents of children with CP, as well as adults with CP. Furthermore, NINDS has created an oversight committee to continuously review the NINDS CDEs for CP.
CONCLUSION
The global adoption of standardized data collection, whenever feasible, will increase opportunities for conducting secondary data analyses and meta-analyses that could advance knowledge about how brain behaviour, functional abilities, and genetics-biology-environment interact dynamically across ages and stages of development of children and young people with CP. Ongoing international collaboration will help ensure that the CDEs are updated and reviewed as additional evidence is obtained. 
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